Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab for Anticoagulation Resistant APS
NCT00537290Phase 2Completed
- Sponsor
- Hospital for Special Surgery
- Start
- Sep 2007
- Primary completion
- Jan 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in antiphospholipid syndrome (APS), sponsored by Hospital for Special Surgery. Started Sep 2007; status: completed.
02
Drugs
rituximab
03
Conditions
antiphospholipid syndrome (APS)
Beyond the preview
Go deeper on NCT00537290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00537290.